CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Obesity-related genetic information disclosure with tailored lifestyle recommendations +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04079972
NCT04079972N/ACompleted

Personalized Lifestyle Intervention Based on SNP Testing and Weight Control

NaNa Keum·interventional·Posted Sep 6, 2019·Updated Jan 6, 2026

In Brief

A clinical study evaluating Obesity-related genetic information disclosure with tailored lifestyle recommendations and Non-obesity-related genetic information disclosure for Weight Loss. Completed, enrolled 53 participants across 1 site.

Detailed Summary

This trial aims to investigate whether tailored lifestyle consultation through SNP testing leads to more effective weight loss among overweight or obese individuals compared to general lifestyle guidance for weight control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWeight Loss
CountriesSouth Korea

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 6, 2019
Enrollment StartJun 11, 2019
Primary CompletionNov 2, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 6.8 years ago

Interventions

Obesity-related genetic information disclosure with tailored lifestyle recommendationsbehavioral

They received their complete SNP results, including obesity-related traits, along with corresponding lifestyle recommendations.

Non-obesity-related genetic information disclosurebehavioral

Provided only with genetic test results related to beauty traits at baseline; information on metabolic health-related SNPs was disclosed only after the final follow-up assessment.